Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes
- 1 February 2005
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 54 (2), 227-234
- https://doi.org/10.1016/j.metabol.2004.08.017
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic ResonanceDiabetes, 2003
- Metabolic origins and clinical significance of LDL heterogeneityJournal of Lipid Research, 2002
- Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart DiseaseCirculation, 2001
- Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in MenCell Metabolism, 1997
- Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention ProjectCirculation, 1996
- Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and womenJAMA, 1996
- A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA, 1996
- LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Detection and quantitation of LDL subfractionsCurrent Opinion in Lipidology, 1992
- Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.Cell Metabolism, 1990